Congressional Testimony 2001

-

October

10/10/2001 Federal Food Safety System
Bernard Schwetz, D.V.M, Ph.D., before the Senate Committee on Governmental Affairs, Subcommittee on Oversight of Government Management, Restructuring, and the District of Columbia

-

09/05/2001 Health Fraud
William K. Hubbard, before the Senate Committee on Consumer Affairs, Foreign Commerce, and Tourism

-

07/24/2001 Prescription Drug Promotion
Nancy M. Ostrove, Ph.D, before the Senate Committee on Consumer Affairs, Foreign Commerce, and Tourism

-

06/20/2001 Availability of Investigational Drugs for Compassionate Use
Robert J. Temple, M.D., before the House Committee on Government reform
06/13/2001 Recent Developments Which May Impact Consumer Access to, and Demand for, Pharmaceuticals
Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health
06/13/2001 Importation of Drugs into the United States
William K. Hubbard, before the House Committee on Energy and Commerce, Subcommittee on Health

-

05/24/2001 Human Tissue Banking
Kathryn C. Zoon, Ph.D, before the Senate Committee on Government Affairs, Permanent Subcommittee on Health
05/24/2001 Implementation of Provisions of the Drug Price Competition and Patent Term Restoration Act of 1984
Gary Buehler, R.Ph., before the Senate Committee on the Judiciary
05/10/2001 Challenges FDA faces in the New Century
Bernard Schwetz, D.V.M., Ph.D., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, and Related Agencies
05/08/2001 Implementation of the Pediatric Exclusivity Provisions
Janet Woodcock, M.D., before the Committee on Health, Education, Labor, and Pensions
05/03/2001 FDA's Progress/Success in Implementing the Food and Drug Administration Modernization Act of 1997 (FDAMA or Modernization Act)
Linda Suydam, D.P.A., before the House Committee on Energy and Commerce

-

04/26/2001 Concerns Regarding a Potential Link Between Vaccines and Autism
Karen Midthun, M.D., before the House Committee on Government Reform
04/04/2001 BSE
Stephen Sundlof, D.V.M., Ph.D., before the Senate Committee on Commerce, Science, and Transportation, Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism

-

03/28/2001 FDA's Role in the Use of Cloning Technology as a Cause for Public Health Concern
Kathryn C. Zoon, Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
03/20/2001 FDA's Progress with Dietary Supplements
Joseph A. Levitt, Esq., before the House Committee on Government Reform
03/08/2001 Challenges of the Next Century
Bernard Schwetz, D.V.M., Ph.D., before the House Committee on Appropriations

-